The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
By 2030, How Much Growth In Market Size Is Expected For The Large Volume Parenteral (LVP) Market?
The large volume parenteral (lvp) market size has experienced significant expansion in recent years. It is anticipated to increase from $13.53 billion in 2025 to $14.76 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 9.1%. Historically, this expansion has been driven by factors including increasing hospitalization rates, a rise in intravenous fluid therapy usage, more surgical procedures, the development of critical care infrastructure, and an increase in infectious disease treatment.
The large volume parenteral (lvp) market is anticipated to show significant expansion in the upcoming years. This sector is projected to reach $21.37 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 9.7%. This forecasted growth can be attributed to an aging global population, the rising occurrence of chronic illnesses, increased demand for parenteral nutrition, the development of healthcare infrastructure in emerging markets, and an expansion of emergency and trauma care services. Major developments expected during this period include a growing preference for non-PVC and eco-friendly lvp packaging, the wider availability of ready-to-use and premixed infusion solutions, a stronger focus on sterility and contamination control, increased utilization of lvps in critical care and emergency medicine, and a rise in hospital-based infusion therapy volumes.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12195&type=smp
Which Strategic Drivers Are Supporting The Large Volume Parenteral (LVP) Market Development?
The increasing occurrence of chronic illnesses is anticipated to fuel the expansion of the large-volume parenteral market. Chronic diseases refer to conditions or ailments that typically persist for three months or longer and may worsen over time. The surge in chronic diseases is primarily influenced by tobacco use, exposure to smoke, and insufficient nutrition. Patients afflicted by these conditions require an appropriate balance of essential nutrients to maintain their strength, and the parenteral administration method guarantees the correct pharmaceutical dosage since most of the drug is absorbed directly into circulation, bypassing the digestive system. For instance, in September 2023, according to the World Health Organization, a Switzerland-based specialized agency of the United Nations, 41 million deaths, which is 74% of the total, were caused by non-communicable diseases (NCDs) or chronic diseases every year globally. Therefore, the growing prevalence of chronic diseases drives the growth of the large-volume parenteral market.
What Segment Categories Are Evaluated In The Large Volume Parenteral (LVP) Market Study?
The large volume parenteral (lvp) market covered in this report is segmented –
1) By Type: Soft Bag LVP, Plastic Bag LVP, Glass Bottle LVP
2) By Volume: 100 ML – 250 ML, 250 ML – 500 ML, 500 ML – 1000 ML, 1000 ML -2000 ML, 2000 And More
3) By Application: Basic Infusion, Therapeutics Infusion, Nutritious Infusion
4) By End-User: Hospital, Medical Centers, Other End Users
Subsegments:
1) By Soft Bag LVP: PVC Soft Bags, Non-PVC Soft Bags
2) By Plastic Bag LVP: Polypropylene Bags, Polyethylene Bags
3) By Glass Bottle LVP: Single-Use Glass Bottles, Multi-Dose Glass Bottles
What Trends Are Shaping The Large Volume Parenteral (LVP) Market Structure?
Companies in the large volume parenteral (LVP) market are actively developing sophisticated infusion-device innovations, specifically intelligent large-volume infusion pumps, to address the escalating demand for safer, more automated, and interconnected intravenous therapy. This demand is fueled by the expansion of hospital-based infusion services, an increase in remote patient monitoring, and the drive for standardized, error-resistant medication delivery. An intelligent large-volume infusion pump is engineered to administer high-volume IV fluids (LVP), featuring integrated dose-error reduction software, connectivity for smart drug libraries, and robust alarm management. Unlike conventional infusion pumps that depend on manual programming and limited automation, these advanced pumps are instrumental in preventing dosing errors, alleviating workflow burdens, and integrating with hospital IT systems. For instance, in April 2024, Baxter International Inc., a US-based pharmaceutical and medical-device company, secured U.S. FDA clearance for its Novum IQ Large-Volume Infusion Pump, which incorporates Dose IQ smart-dose software. This device facilitates high-rate fluid delivery, including large-volume infusions, and includes safety functionalities like drug library integration to minimize dosing inaccuracies, alongside enabling connectivity to hospital electronic medical records and smart monitoring platforms. By ensuring safe, automated, and dependable infusion of large volumes, the Novum IQ pump assists healthcare providers in enhancing infusion accuracy, reducing the potential for dosing mistakes, and optimizing high-volume IV therapy workflows.
Which Companies Are Engaged In The Large Volume Parenteral (LVP) Market Environment?
Major companies operating in the large volume parenteral (lvp) market are Pfizer Inc., Fresenius Kabi AG, Abbott Laboratories Inc., Otsuka Holdings Co. Ltd., Baxter International Inc., B. Braun Melsungen AG, Grifols S.A., Cipla Limited, ICU Medical Inc., Biocon Limited, Sichuan Kelun Pharmaceutical Co. Ltd., Alembic Pharmaceuticals Limited, Cadila Healthcare Ltd., Gland Pharma Limited, Akums Drugs & Pharmaceuticals Ltd., Beximco Pharmaceutical Ltd., Taj Pharmaceuticals Limited, Albert David Ltd., Amanta Healthcare Ltd., Unique Pharmaceutical Laboratories Ltd., Ahlcon Parenterals India Ltd., Parenteral Drugs Limited, Abaris Healthcare Pvt. Ltd., BML Parenteral Drugs, Denis Chem Lab Ltd., Pentagon Labs Ltd., DJ Labs Pvt. Ltd., Higgs Healthcare
Access The Complete Large Volume Parenteral (LVP) Market Report:
https://www.thebusinessresearchcompany.com/report/large-volume-parenteral-lvp-global-market-report
Which Region Contributes The Most To The Large Volume Parenteral (LVP) Market?
North America was the largest region in the large volume parenteral (LVP) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the large volume parenteral (lvp) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access Large Volume Parenteral (LVP) Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/customise?id=12195&type=smp
Browse Through More Reports Similar to the Global Large Volume Parenteral (LVP) Market 2026, By The Business Research Company
Small Volume Parenteral Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/small-volume-parenteral-global-market-report
Small Volume Parenteral Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/small-volume-parenteral-global-market-report
Parenteral Nutrition Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/parenteral-nutrition-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model